Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate on Symptom Improvement in Patients With Peripheral Arterial Disease

NCT05083299 is registered in ClinicalTrials.gov with Daewoong Pharmaceutical Co. LTD. as lead sponsor.

NCT NCT05083299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05083299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate on Symptom Improvement in Patients With Peripheral Arterial Disease
Lead sponsor
Daewoong Pharmaceutical Co. LTD.
Phase
Observational
Overall status
Completed
Start date
January 28, 2020
Completion date
January 20, 2022
Enrollment
1,003 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic occlusive arterial disease